ALK rearrangement in a large series of consecutive non-small cell lung cancers: comparison between a new immunohistochemical approach and fluorescence in situ hybridization for the screening of patients eligible for crizotinib treatment.

摘要

Our results show that IHC may be a useful technique for selecting NSCLC cases to undergo ALK FISH analysis.